✦ LIBER ✦

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

✍ Scribed by Speakman, Mark; Khullar, Vik; Mundy, Anthony; Odeyemi, Isaac; Bolodeoku, John

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolterodine once-daily in treatment of t

✍ Kenneth M Peters; Raywin R Huang 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 39 KB

PUK20 A COST EFFECTIVENESS ANALYSIS OF S

✍ HH Kang; JY Bae; SY Park; HS Sohn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

The cost utility of solifenacin in the t

✍ Leona Hakkaart; Paul Verboom; Richard Phillips; Maiwenn J. Al 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 181 KB

Tolterodine once-daily in treatment of t

✍ Philip Van Kerrebroeck 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Tolterodine once-daily: superior efficac

✍ Philip Van Kerrebroeck; Karl Kreder; Udo Jonas; Norm Zinner; Alan Wein 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

PUK11 A COST-UTILITY ANALYSIS OF SOLIFEN

✍ L Cardozo; A Thorpe; M Grishchenko; MK Sidhu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB